Jeff Knight
Operationeel Directeur bij CRINETICS PHARMACEUTICALS, INC.
Vermogen: 2 M $ op 30-04-2024
Profiel
Jeff E Knight is currently the Chief Operating Officer at Crinetics Pharmaceuticals, Inc. He previously worked as the Executive Director-Global Development Operations at Amgen, Inc. from 2015 to 2017, as the VP-Clinical Operations & Project Management at Onyx Pharmaceuticals, Inc. from 2012 to 2015, as the VP-Development Operations & Portfolio Management at Halozyme Therapeutics, Inc. from 2017 to 2018, and as the SVP-Portfolio Management & Corporate Operations at Poseida Therapeutics, Inc. from 2018 to 2021.
Mr. Knight received his undergraduate degree from the University of Kansas and his graduate degree from the University of Oklahoma.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-04-2024 | 52 580 ( 0.07% ) | 2 M $ | 30-04-2024 |
Actieve functies van Jeff Knight
| Bedrijven | Functie | Begin |
|---|---|---|
| CRINETICS PHARMACEUTICALS, INC. | Operationeel Directeur | 30-08-2021 |
Eerdere bekende functies van Jeff Knight
| Bedrijven | Functie | Einde |
|---|---|---|
| POSEIDA THERAPEUTICS, INC. | Corporate Officer/Principal | 31-08-2021 |
| HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | 01-10-2018 |
| AMGEN INC. | Corporate Officer/Principal | 01-03-2017 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Corporate Officer/Principal | 01-07-2015 |
Opleiding van Jeff Knight
| University of Kansas | Undergraduate Degree |
| University of Oklahoma | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| POSEIDA THERAPEUTICS, INC. | Health Technology |
| HALOZYME THERAPEUTICS, INC. | Health Technology |
| AMGEN INC. | Health Technology |
| CRINETICS PHARMACEUTICALS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
